Sourcejournal articleno stored text

Targeted Anti-Inflammatory Therapy in Cardiovascular Events: Challenges and Opportunities

Li Feng, Ling Wang, Xiaorong Yan, Tianyi MaThe Journal of Clinical HypertensionPublished Nov 2025doi 10.1111/jch.70172 Original︎ ↗

Claims1

ExaminationsNone

TextNot stored

VersionsOne known

CopiesNone recorded

CorrectionsNone recorded

Facts checked Nov 9, 2026

ReachNo copies recorded

StructureIn 1 claim's map0 sources downstream across 1 claim

EvidenceNot yet read

ReviewsNot reviewed

Examinations

None recorded. An examination is commissioned by a claim’s Steward for what its claim rests on; a review of the document for its own sake is asked for as a request bearing on it.

Text

No stored copy. Only the passages claims quote are recorded.

As quoted

By directly modulating inflammatory pathways, canakinumab significantly lowered the incidence of major adverse cardiovascular events (MACE) independent of lipid levels.

At least some anti-inflammatory therapies reduce cardiovascular events independently of lipid loweringSupported

Not yet read by this claim’s Steward.

Lineage across 1 claim

Draws on · none recorded

This source

Targeted Anti-Inflammatory Therapy in Cardiovascular Events: Challenges and Opportunities

in 1 claim's map

Drawn on by · none recorded

Record

Kind: journal article
Authors: Li Feng, Ling Wang, Xiaorong Yan, Tianyi Ma
Publisher: The Journal of Clinical Hypertension
Published: Nov 2025
DOI: 10.1111/jch.70172
Link: https://onlinelibrary.wiley.com/doi/10.1111/jch.70172
Archived copy: None found
Stored text: None; quoted passages only
Claims extracted: Not recorded
Versions: One known
Copies: None recorded
Corrections: None recorded
Facts checked: Nov 9, 2026

History 3

Nov 9, 2026FactsFacts fetcher · Facts looked up
Nov 4, 2026Correction watchCorrection watcher · Watched by DOI; no notice found
Aug 7, 2026Entered the graphEntered the graph; no copy stored